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THE ETHICS AND POLITICS OF STEM CELL RESEARCH
BY

James C. Bobrow, MD*

ABSTRACT
Introduction: Because of the many ocular diseases that may benefit from genetic alteration, ophthalmology will be embroiled in the
controversy over the ethics of stem cell research. In preparation for a major academic symposium at the Washington University
School of Medicine, the direct and indirect effects of political efforts to determine whether this research should be funded were
explored.
Methods: A symposium was held at Washington University School of Medicine sponsored by the Barnes-Jewish Hospital Medical
Staff Association to discuss the scientific basis of stem cell research. The forces arrayed on either side of the argument are presented
as well as the political context in which they are being played out.
Results: Two kinds of effects are expected from this controversy: direct effects on current and proposed research efforts from both
within and outside the academic milieu and indirect effects on research funding from state and federal sources influenced by the
political process.
Conclusion: This report serves to document the efforts of one scientific community to deal with a legislative initiative to criminalize
stem cell research for both the scientist and the patient. The process and interim conclusions may be instructive for those involved in
this endeavor to recognize the dynamics of the interaction between society and science when ethical issues influence how decisions
are made.
Trans Am Ophthalmol Soc 2005;103:138-142

INTRODUCTION
Stem cell research is at the heart of the genomic revolution that will transform our ability to affect the course of disease states in the
next 100 years. The elucidation of the human genome has allowed us to begin to find the aberrations in gene function that result in
phenotypic alterations in organ systems. Although we do not pretend to understand at this point how to reorganize base pair sequences
to manufacture novel proteins, we know that at critical junctures substitutions, deletions, missense mutations, and early terminations
of protein sequencing will impair the organism’s structure or function. What we are discovering is that we are able to “repair” these
defects by adding or replacing the malfunctioning protein with a normal one or by introducing a cell population that has the potential
to provide the correct substance and allow biochemical reactions to proceed as they would in a “normal” organism.
These alterations have enormous potential. They have been likened to the introduction of antibiotics 70 years ago. But the results
from these investigations will come more slowly, their correct use will require trial and error, and their power also carries the
opportunity for misuse. That this era is here we can have no doubt.
Two categories of stem cell production are at issue in the present debate: (1) those derived from fertilized eggs (embryonic stem
cells or reproductive cloning) and (2) those derived from DNA taken from other sources (somatic nuclear cell transfer [SNCT]).
In the Figure, the differences in these techniques are illustrated. The source of the nuclear material differs according to the origin
of the cell line. In embryonic stem cells, the source is sexual reproduction with one half of the chromosomal material from the ovum
and half from the sperm. In SNCT, both halves of the genetic material come from the same donor, replacing the haploid material of
the unfertilized ovum with diploid material from the nucleus of the somatic cell. Whereas, theoretically, both blastocysts, if implanted
in a uterus, will form a fetus, the destination for the inner cell mass in the blastocyst in SNCT is a cell culture that will ultimately grow
into an immortal cell line of skin cells, neurons, or other distinct cell types for use in replacing or supplementing missing proteins or
enzymes in a variety of disease states.

METHODS
The first task is to separate out the scientific factors from the ethical and religious arguments for stem cell research. For the scientist,
the goals are advancement of knowledge and treatment of disease. The pitfalls are perversion of efforts toward advancement of
knowledge to self-aggrandizement, misrepresentation of the true effects of treatment, and use of these methods to affect attributes that
are not disease states. Within the scientific community, the regulatory process includes peer review of proposals, institutional review
by human studies committees, and a set of guidelines that specify what stem cells are being used, the sources from which they come,
and how the resultant cell lines and cultures will be handled and guarded. Oversight, including input from lay personnel, remains a
hallmark of the credentialing process and avoids the criticism that experiments are being conducted without transparency for all steps
in the process. The explicit prohibition against cloning or use of the products of SNCT for reproduction has been incorporated into the
legislation passed in California and New Jersey and in the United Kingdom.
In Missouri, the two major institutions that stand poised to implement stem cell techniques in their research efforts are Washington
University and the Stowers Institute in Kansas City. Washington University is the site of the federally funded Human Genome Project
that resulted in the elucidation of the human genome.
From the Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri.
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FIGURE
Methods of creating stem cells: embryonic versus somatic nuclear cell transfer. (Reprinted
with permission from Steven Teitelbaum, MD, Professor of Pathology, Washington
University, St Louis, Missouri.)
Efforts at biomedical engineering have been encouraged from both private and public sources. The Stowers Institute for Medical
Research was founded by James and Virginia Stowers to advance knowledge in the field of genomics.
Simultaneous bills were introduced in the Missouri Senate and House in early 2005 to criminalize stem cell research. The
biomedical and research community was slow to respond because of a lack of understanding of the legislative process, a “cottage
industry” approach to the global effect of the restrictions advocated, a leadership vacuum, and a reluctance to confront the forces
arrayed against stem cell research. The bills have been tabled, as will be discussed below, but the potential issues and forces arrayed
on each side may be assessed. Although the parameters of a research presentation do not conform exactly to the mechanics of a social
or political process, I will attempt to approach this subject in an epidemiologic fashion.
The second task is to look at the efforts to regulate stem cell transplantation. The two sources of regulation are political and
ethical/moral/religious. For legislative regulation to be successful, it must be explicit and clearly defined. Sources of stem cells that are
permitted and forbidden need to be delineated and the uses to which they are put outlined to avoid ambiguity, suspicion, and legal
challenge. More difficult is the distinction about egality of moral belief systems. As Ambassador John Danforth commented, “The
proposal to criminalize cell regeneration research calls for a choice between two understandings of human life. On the one hand, we
have the millions of people who suffer from ALS, Alzheimer’s, juvenile diabetes, Parkinson’s, spinal cord injuries, and cancer—and
the loved ones who care for them and suffer by their sides. On the other hand, we have tiny bundles of unfertilized cells existing in
Petri dishes. Supporters of the legislation (to criminalize stem cell research) should explain to the afflicted and their loved ones why
they care more about those cell bundles than they do about the people.”1
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The bills presented to the Missouri Legislature (identical in the House and Senate) sought to levy a fine and impose imprisonment
on both the physician and the patient involved in stem cell research. The legislation is so far-reaching that it actually may be invoked
if a patient receives treatment that involves stem cell research in another state and returns to Missouri. Governor Matt Blunt stated that
he would veto the bill in its present form, but he has risked alienating part of his constitutency with his stance.

RESULTS
Stem cell research holds the prospect of relief from suffering for groups of people who have acute and chronic conditions that may
become less onerous and life-threatening if the missing substrates and enzymes are replaced by cells that replace the abnormal DNA.
Those who oppose stem cell research argue that the mechanism for relieving that suffering represents an illegal transfer of human cells
and cite that the relief provided to those in need makes the deliverers and recipients equally criminal. They justify their belief by
stating that the stem cells are a by-product of human organisms. These same arguments were utilized in the world-wide debate on
organ transplant; however, these procedures have become an accepted practice for which no penalty is exacted in almost all cultures.
Unfortunately, scientific research will continue to extend into spheres that are considered “sacred.” If the safeguards of morality
and legislative penalty for acts beyond the scope of respected medical practice are enforced, the risk that the privilege of using
unfertilized ova for somatic nuclear cell transfer will be abused is small.
A symposium entitled “Stem Cell Research: Current Status and Future Challenges” was hosted by the Barnes-Jewish Hospital
Medical Staff Association, the Washington University School of Medicine, and the Institute for the Study of Ethics and Human
Values at Washington University and was held on February 15, 2005. The speakers limited their discussions to the science of stem cell
research. Four hundred members of the university community attended, and the symposium was recorded on DVD and disseminated
to those who could not attend. Challenges to the format of the meeting were raised both from within the medical community and from
the St Louis community, objecting to the absence of a discussion of the ethics and religious views. An additional meeting was
organized on April 14, 2005, to address these topics. The organizers of the symposium felt that understanding the nature of SNCT and
its potential to relieve suffering and save lives should be emphasized in order to counteract the criminalization legislation.
Since the symposium at Washington University School of Medicine, 2,300 individuals have joined the Missouri Coalition for
Lifesaving Cures. A poll taken by the St Louis Post-Dispatch has revealed that 66% of Missourians are in favor of stem cell research.
Several religious organizations have threatened elected officials that a vote against the bills would engender a concerted opposition to
their next candidacy.2 Preachers in many pulpits have made their views known to their congregations both for and against the
legislation. In some Christian denominations, threats of denial of access to the Sacraments were made, although they have not caused
widespread concern. A midterm election for a State Senate seat occasioned by the resignation of the present Senator turned into a
referendum on the stem cell research legislation with groups outside of the district and even outside of Missouri contributing large
sums to each candidate.3 The candidate supported by those opposed to stem cell research won by a narrow margin.
In Missouri, the debate in the Senate was terminated, and the bill was withdrawn by its sponsor. The Republican majority became
divided when faced with the political dilemma of choosing between the business considerations of driving potentially remunerative
scientific endeavor from Missouri and the putative political damage that voting on the bill would have caused among the electorate.4

DISCUSSION
The use of nuclear material from somatic cells implanted in unfertilized ova permits the creation of stem cells that are close to the
omnipotent cells released by the blastocyst after fertilization but before implantation in the uterine wall. These cells grown in culture
are capable of becoming immortal and of being used to release proteins that may influence the course of genetically modifiable
diseases whether incipient or established in the new host.
Those who argue against stem cell research state that, no matter how beneficial the results from this form of scientific inquiry, the
fact that life has been destroyed in order to create stem cells is sufficient evidence that the research is unethical. For this argument, the
responses that SNCT involves an unfertilized egg, that the female creates and discards several unfertilized eggs per month, or that
these eggs if harvested would not in the process of SNCT create life, because they would not produce a differentiated organism, nor
destroy life, because the unfertilized egg with haploid genetic material would not be able to reproduce itself, fall on deaf ears.
Those who argue in favor of stem cell research fall into two categories. In the first are those who feel that they must refute the
arguments of those who oppose stem cell research. They fail to take into account that their opponents’ argument depends on the
definition of when life begins, a sacred text that yields no truth because it is potentially “unknowable.” The second group chooses to
reframe the question in terms of benefit. The criticism of this argument is the moral relativism of choice between helping many at the
expense of a few. With SNCT, we are directing life to promote life, not exchanging one life for another. In much the same way, the
conception of a child to provide bone marrow to a sibling with a reticuloendothelial or hematologic malignancy is countenanced
because the younger child will be loved not only for the donation but for itself.
The successful support for ethical stem cell research must come from reframing the argument. Some have chosen to discuss the
justice of helping others. Others have invoked the exploration of the unknown as a primary obligation of science. Still others have
used the teleologic argument for survival. But ethical justification supersedes scientific intellectual reasoning when the consequences
of misused genetic material may be devastating. Each step in the scientific investigation must hold the reasonable promise of a
beneficial result. Pain or morbidity may be acceptable but only with the expectation of gain. Thus, we may cut the skin and
integument to reveal the diseased organ whose removal or repair will make the body whole again. Similarly, we may lyse the cell
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membrane of an unfertilized egg as long as we allow other eggs to be fertilized to grow into new individuals and as long as we
reconstitute the cell membrane of the unfertilized egg into a new cell that we intend to use to make the organism whole or to relieve
suffering.
Our task is difficult. First, the scientific community must present its view of the processes and consequences of stem cell research
in a balanced fashion: who will benefit, who will be harmed, from what sources stem cells may come, and to what uses they will be
put. Second, the distinction between stem cell research and cloning of individuals must be clarified. Third, the scientific community
must address the opposing arguments and must emphasize that the goals of stem cell research are the preservation and improvement of
life.
Both the economics and the ethics of stem cell research are under attack. Effective education and discussion of risks and benefits
are the weapons of mass dissemination that will allow this research to proceed. Criminalization and subsequent migration of
researchers from unfavorable to favorable environments have already begun. The battle is being fought on a state-by-state basis. Our
efforts to understand and educate ourselves and our legislators will affect the course of stem cell research in the United States for
many years.
We stand at a crossroads, looking toward freedom from the ravages of chronic diseases. As we have done so many times in the
past, we face the challenge of responsible leadership and making the individual and collective effort to inform and influence the path
of knowledge and understanding. The stakes are high, but the promise of a cellular approach to the repair of genetic dysfunction
should impel us to use our best efforts to aid our patients.
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PEER DISCUSSION
DR SUSAN H DAY. Dr Bobrow encourages us all to become educated and involved in the future of stem cell research in the United
States. The specific political issue addressed relates to events in his own state, Missouri, with the outlined response from Washington
University. He highlights the uniqueness of stem cell research from the standpoint of public interest and perspective; in essence, the
politics of stem cell research represent an extension of the public’s ongoing debate over abortion.
Why is this research within the realm of public interest? Research support continues to be heavily supported from governmental
funding. Further, the potential for international collaboration creates the need for rules regulating such interchange. Finally, the
possibility that stem cell research will lead to usable products within medicine results in requisite input from the Food and Drug
Administration.
Our existing governmental regulations fail to fully address the entire scope of human stem cell (hES) research. There are
overlapping regulations which address donor human subjects, medical privacy, laboratory standards, animal rights, and importation of
biological material. In general, the federal government is responsible for regulations which impact where its medical research dollars
are spent, but it has traditionally been state legislatures that address embryo protection. Institutional regulations have governed
adherence to these guidelines.
By contrast, other countries have addressed stem cell research more completely. The United Kingdom, Israel, Canada, Singapore
among others all have well-developed policies. France, Germany, and Sweden have more limited policies developed. Poland and
Italy prohibit stem cell research. The existing political climate in the United States has centered dialogue about stem cell research in
moralistic tones; President Bush has stated he would veto a bill on stem cell research which is currently being debated in the House,
vowing that “the use of federal money, taxpayers’ money, to promote science which destroys life in order to save life, is – I am against
that.” 1
The price of avoiding federal legislation has resulted in several phenomena. First, the states are left to define standards. California
passed a $3 billion dollar initiative; as a result, recruiters are finding an easy task luring researchers from states in which tighter
restrictions exist.2 Industry has entered stem cell research, and countries such as South Korea are gaining headlines for early hES cell
resarch.
The respected National Academies has just issued its Guidelines for Human Embryonic Stem Cell Research.3 It identified the
ethical issues raised by hES cell research as: 1) special status of the human embryo; 2) respect for donors of embryos/ gametes; 3)
transfer of hES cells into nonhuman animals; and 4) objections to nuclear transfer for reproductive purposes. It proposes a national
forum in which individuals representing scientific, medical, ethical, legal backgrounds develop guidelines that ensure a just
distribution of benefits and of sufficient genetic diversity. It also proposes the equivalent of IRB’s locally: embryonic stem cell
research oversight (ESCRO) committees, to assure adherence to these guidelines.
It is only with dialogue among the appropriate representatives from those with diverse backgrounds that necessary guidelines will
be developed in the United States. The usual resolution of an ethical dilemma, in which principles lead to rules (regulations) that in
turn by experience challenge these rules, must play out in the arena of stem cell research. This extraordinary new frontier in science,
as with all advances in science, will profit from thoughtful, interdisciplinary dialogue.
Trans Am Ophthalmol Soc / Vol 103/ 2005

141

The Ethics and Politics of Stem Cell Research

REFERENCES
1.
2.
3.

Stolberg S. Bush vows to veto stem-cell bill. Dallas Star-Telegram. 21 May 2005 p3a.
Wade N. Stem cell researchers feel the pull of the Golden State. New York Times. 22 May 2005 p24.
The National Academies. Guidelines for human embryonic stem cell research (2005). Available at
http://www.nap.edu/books/0309096537/html. Accessed May 24, 2005.
DR ALLAN J. FLACH. This might be an appropriate subject matter for an AOS Knapp Symposium in the future.
DR GEORGE O. WARING III. The American Academy of Ophthalmology might also consider a symposium on this topic. This is
somewhat analogous to Copernicus and Galileo: having religion challenge science.
DR STEPHEN J. RYAN. The National Alliance for Eye and Vision Research represents over 50 organizations in ophthalmology and
vision research and are part of Research!America, which represents over 500 organizations in the country that support this House bill,
the so called Castle Bill 810, which will be voted on today in the House of Representatives. It is related to politics in the state of
Missouri and the state of California. The National Academies Report, as Dr Day mentioned, is a well-balanced report. Zach Hall,
Ph.D. is the president of the California Institute of Regenerative Medicine and very knowledgeable about this topic. If you visit their
website at www.cirm.ca.gov this issue is discussed in detail. The real question is, “How do we make our views known as to where the
future should be headed, especially in relation to the excellent symposia that we heard yesterday?”
DR JAMES C BOBROW. Recent newspaper accounts have indicated that the South Koreans have found a way to increase the
number and speed with which stem cells can be created. At this point in the United States we are not at the forefront of the research
that is being done. In response to Dr Day, I agree that we must deal with research embryo protection and appropriate guidelines. In
California a $3 billion initiative has been approved to encourage stem cell research. In the state of Missouri, Virginia and James
Stowers endowed the Stowers Center in Kansas City with private funding of $2 billion as seed money for stem cell research. The
Stowers threatened, during the course of the debate about this bill in the Missouri Congress, to take the remainder of their money and
go elsewhere to start another institute for this purpose. So this type of research may very well require private funding if the public
arena is not the appropriate place. Certainly the National Academy of Sciences report appeared after the preparation of my paper; I
certainly hope that this balanced report and its recommendations are adopted. I encourage all of you to consider this a personal as well
as a scientific endeavor and avoid disengaging yourself from the legislative process. Dr Flach has suggested that this might be part of
a future Knapp Symposium. Since this year’s Knapp symposium was on tissue regeneration, I thought that my topic was
complementary. Perhaps there are additional forums in which these matters might be discussed, including the AAO, as Dr Waring has
suggested.
As far as Copernicus and Galileo are concerned, each continued his studies in spite of the resistance of the reigning religious
dogma of the time; although Galileo, after recanting, spent his remaining years under house arrest. I hope perhaps under some
circumstances we will also be allowed to continue this research whether it be under private funding, public funding or in some other
way.
Dr Ryan is correct. The California initiative does contain fascinating reading. I also encourage you to access that website.
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